Welcome to Advanced Search

HCC-95

Strain Name：HCC-95
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-F22

HCC-95 is a human non-small cell lung cancer (NSCLC), squamous cell carcinoma cell line.

Ca Ski

Strain Name：Ca Ski
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-Z03

Ca Ski cell line is derived from an epidermoid carcinoma of the cervix metastatic to the small bowel mesentery of a 40-year-old Caucasian.

NCI-H2030

Strain Name：NCI-H2030
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-F20

H2030 is a cell line exhibiting epithelial morphology that was isolated in 1988 from the lungs of a non-smoking male with non-small cell lung cancer.

NCI-H446

Strain Name：NCI-H446
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-FX02

The NCI-H446 cell line was derived by D. Carney, A.F. Gazdar and associates in 1982 from the pleural fluid of a patient with small cell cancer of the lung.

NCI-H1975 [H-1975, H1975]

Strain Name：NCI-H1975 [H-1975, H1975]
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-F07

NCI-H1975 (H-1975, H1975) is a cell line exhibiting epithelial morphology that was isolated in 1988 from the lungs of a nonsmoking female with non-small cell lung cancer.

Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation

Model Organisms：Zebrafish Product & Service：EGFL6，pax6a Research field：Angiogenesis

E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer

Model Organisms：小鼠 Product & Service：Mkrn3-Flox Research field：Cancer Research

Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a...

Model Organisms： Product & Service：M-NSG Research field：Lung Carcinoma

Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical...

Model Organisms：小鼠 Product & Service：M-NSG Research field：Non-Small Cell Lung Carcinoma

Webinar on Advances in Antibody-Drug Conjugates (ADCs) Development & Preclinical Models

Antibody-Drug Conjugates ADC Development Preclinical Models Targeted Cancer Therapies GenoBioTX ADC Webinar Biopharma Research Oncology Biochemistry Cancer Treatment Preclinical Evaluation Monoclonal Antibodies Small Molecule Drugs

Join us for a webinar on June 26th, 2024, exploring the development and preclinical evaluation of Antibody-Drug Conjugates (ADCs). Learn from Dr. Hua Wei, VP of the Industrial Clients Department at GenoBioTX, about ADC components, mechanisms, historical evolution, and future directions.